Riskpilot← Back to searchSign inGet full accessNIAZMED AS
ASActiveOrg 928414566Gladbakkvegen 2A, 2070 RåholtMedical specialists activities · NACE 8622Est. 20212 employees
Revenue 2024
NOK 10,7M
+10% vs 2023
EBITDA margin
14.2%
+1% vs 2023
Equity ratio
1.3%
Financial strength
Net profit 2024
NOK 1,2M
+3% vs 2023
| Revenue | NOK 10,7M | +10% |
| EBITDA | NOK 1,5M | +1% |
| Net profit | NOK 1,2M | +3% |
| Total assets | NOK 3,7M | +59% |
| Equity | NOK 46K | -96% |
| Employees | 2 | — |
Legal name
NIAZMED AS
Org number
928414566
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
20. desember 2021
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Spesialisert legetjeneste innenfor øre-nese-hals sykdommer, konsulentvirksomhet, rådgivning og opplæring, deltakelse i andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Gladbakkvegen 2A, 2070 Råholt
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 6 759 | 9 749 | 10 716 |
| Staff expenses | −0 | −2 773 | −3 241 | −3 354 |
| EBITDA | −4 | 1 395 | 1 506 | 1 527 |
| Depreciation & amort. | −0 | −0 | −0 | −40 |
| EBIT | −4 | 1 395 | 1 506 | 1 487 |
| Net financials | 0 | 0 | 0 | 54 |
| Profit before tax | −4 | 1 395 | 1 506 | 1 541 |
| Tax | −0 | 304 | 332 | 327 |
| Net profit | −4 | 1 092 | 1 173 | 1 214 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 30 | 1 933 | 2 298 | 3 662 |
| Equity | 15 | 110 | 1 283 | 46 |
| Long-term debt | 0 | 2 | 16 | 1 |
| Short-term debt | 15 | 1 821 | 999 | 3 615 |
| Total debt | 15 | 1 823 | 1 015 | 3 616 |
EBITDA margin
14.2%
This company
15.8%
Market median
-10% vs market
20212024
Equity ratio
1.3%
This company
38.2%
Market median
-97% vs market
20212024
Return on equity
2610.1%
This company
18.4%
Market median
+14085% vs market
20212024
Net profit margin
11.3%
This company
8.1%
Market median
+40% vs market
20212024
Asset turnover
2.93×
This company
1.12×
Market median
+162% vs market
20212024
Debt / equity
77.76×
This company
0.62×
Market median
-12442% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-10-27 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Niazmed Holding As
NIAZMED AS Board members of NIAZMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amer Mohammad Niaz | Chief Executive Officer | 0 companies |
| Nazanin Hejaz Niaz | Board of Directors | 0 companies |